Physician profile
Katherine King
NPI 1619544194
$1,483.52
in general payments reported to CMS, 2019-2025
17 companies · $412 in 2025
The $412 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $694 · 2023: $159 · 2024: $218 · 2025: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $789.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $380.78 | 2024-2025 | Krystexxa, Repatha, Otezla |
| Novo Nordisk INC | $192.76 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $190.53 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $129.02 | 2022-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Bayer Healthcare Pharmaceuticals INC. | $124.28 | 2022 | |
| Novartis Pharmaceuticals Corporation | $122.52 | 2022-2023 | |
| Lilly USA, LLC | $92.72 | 2022-2025 | Mounjaro, Zepbound |
| Horizon Therapeutics Plc | $72.54 | 2022-2023 | Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.06 | 2022-2025 | Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $18.27 | 2022 | |
| Baxter Healthcare | $15.91 | 2022 | |
| Philips North America LLC | $13.70 | 2023 | |
| Dexcom, INC. | $13.46 | 2022 | |
| Pfizer INC. | $13.17 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.90 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $12.72 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.